Skip to main content

McKune John's Form 4/A amendment

Amended

Pulmonx Corp (LUNG) · filed Mar 7, 2024

Accession no.
0001415889-24-007232
Filed
Mar 7, 2024
Trade date
Mar 1, 2024
Filing delay
6 days
Rule 10b5-1 plan
Not checked
Original filed
Mar 5, 2024

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $9.77K. It was filed 6 days after the trade.

This amendment replaces 0001415889-24-006843 (filed Mar 5, 2024).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
McKune JohnCIK 0001650427Officer (INTERIM CFO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 1, 2024Common StockSSaleDisposed−155$9.06−$1,404.348,333Direct
Mar 1, 2024Common StockSSaleDisposed−254$9.06−$2,301.2448,079Direct
Mar 1, 2024Common StockSSaleDisposed−669$9.06−$6,061.1447,410Direct
Mar 1, 2024Common StockAGrant or awardAcquired+28,800$0.00$076,210Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 1, 2024Common StockAGrant or awardAcquired+14,400$0.00$014,400Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)